| Title : Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease - Hager_2014_Neuropsychiatr.Dis.Treat_10_391 |
| Author(s) : Hager K , Baseman AS , Nye JS , Brashear HR , Han J , Sano M , Davis B , Richards HM |
| Ref : Neuropsychiatr Dis Treat , 10 :391 , 2014 |
| Abstract : Hager_2014_Neuropsychiatr.Dis.Treat_10_391 |
| ESTHER : Hager_2014_Neuropsychiatr.Dis.Treat_10_391 |
| PubMedSearch : Hager_2014_Neuropsychiatr.Dis.Treat_10_391 |
| PubMedID: 24591834 |
| Title : The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial - Prins_2014_Alzheimers.Res.Ther_6_47 |
| Author(s) : Prins ND , van der Flier WA , Knol DL , Fox NC , Brashear HR , Nye JS , Barkhof F , Scheltens P |
| Ref : Alzheimers Res Ther , 6 :47 , 2014 |
| Abstract : Prins_2014_Alzheimers.Res.Ther_6_47 |
| ESTHER : Prins_2014_Alzheimers.Res.Ther_6_47 |
| PubMedSearch : Prins_2014_Alzheimers.Res.Ther_6_47 |
| PubMedID: 25478019 |